China Pioneer Pharma Holdings Limited (1345.HK)

HKD 2.26

(1.35%)

EBITDA Summary of China Pioneer Pharma Holdings Limited

China Pioneer Pharma Holdings Limited's latest annual EBITDA in 2023 was 201.87 Million CNY , down -18.53% from previous year.
China Pioneer Pharma Holdings Limited's latest quarterly EBITDA in 2023 FY was N/A , down -18.53% from previous quarter.
China Pioneer Pharma Holdings Limited reported an annual EBITDA of 245.37 Million CNY in 2022, up 22.71% from previous year.
China Pioneer Pharma Holdings Limited reported an annual EBITDA of 199.96 Million CNY in 2021, up 146.21% from previous year.
China Pioneer Pharma Holdings Limited reported a quarterly EBITDA of N/A for 2023 FY, down -18.53% from previous quarter.
China Pioneer Pharma Holdings Limited reported a quarterly EBITDA of 52.66 Million CNY for 2023 Q2, down 0.0% from previous quarter.

Annual EBITDA Chart of China Pioneer Pharma Holdings Limited (2023 - 2010)

Historical Annual EBITDA of China Pioneer Pharma Holdings Limited (2023 - 2010)

Year	EBITDA	EBITDA Growth
2023	201.87 Million CNY	-18.53%
2022	245.37 Million CNY	22.71%
2021	199.96 Million CNY	146.21%
2020	104.78 Million CNY	-44.81%
2019	161.31 Million CNY	-6.72%
2018	157.74 Million CNY	-46.15%
2017	292.91 Million CNY	14.54%
2016	255.73 Million CNY	-7.79%
2015	243.63 Million CNY	-4.98%
2014	291.85 Million CNY	14.99%
2013	287.64 Million CNY	16.71%
2012	219.09 Million CNY	70.33%
2011	131.11 Million CNY	22.62%
2010	103.84 Million CNY	0.0%

Year	EBITDA	EBITDA Growth
2023 Q4	98.31 Million CNY	0.0%
2023 FY	- CNY	-18.53%
2023 Q2	52.66 Million CNY	0.0%
2022 Q4	137.68 Million CNY	0.0%
2022 Q2	107.69 Million CNY	0.0%
2022 FY	- CNY	22.71%
2021 FY	- CNY	146.21%
2021 Q2	98.18 Million CNY	0.0%
2021 Q4	101.78 Million CNY	0.0%
2020 FY	- CNY	-44.81%
2020 Q2	35.91 Million CNY	0.0%
2020 Q4	45.3 Million CNY	0.0%
2019 Q4	86.25 Million CNY	0.0%
2019 Q2	60.89 Million CNY	0.0%
2019 FY	- CNY	-6.72%
2018 Q2	125.82 Million CNY	0.0%
2018 FY	- CNY	-46.15%
2018 Q4	31.91 Million CNY	0.0%
2017 Q4	147.3 Million CNY	0.0%
2017 Q2	145.6 Million CNY	0.0%
2017 FY	- CNY	14.54%
2016 Q4	131.5 Million CNY	0.0%
2016 Q2	124.23 Million CNY	0.0%
2016 FY	- CNY	-7.79%
2015 FY	- CNY	-4.98%
2015 Q2	167.23 Million CNY	0.0%
2015 Q4	110.09 Million CNY	0.0%
2014 FY	- CNY	14.99%
2014 Q2	155.78 Million CNY	0.0%
2014 Q4	136.06 Million CNY	0.0%
2013 Q2	103.42 Million CNY	0.0%
2013 Q4	150.38 Million CNY	0.0%
2013 FY	- CNY	16.71%
2012 Q4	72.56 Million CNY	32.09%
2012 Q2	54.93 Million CNY	0.0%
2012 Q3	54.93 Million CNY	0.0%
2012 Q1	54.93 Million CNY	0.0%
2012 FY	- CNY	70.33%
2011 Q1	32.44 Million CNY	0.0%
2011 Q3	32.44 Million CNY	0.0%
2011 Q2	32.44 Million CNY	0.0%
2011 Q4	54.93 Million CNY	69.33%
2011 FY	- CNY	22.62%
2010 FY	- CNY	0.0%
2010 Q3	24.79 Million CNY	0.0%
2010 Q2	24.79 Million CNY	0.0%
2010 Q1	24.79 Million CNY	0.0%
2010 Q4	32.44 Million CNY	30.82%
2009 Q4	24.79 Million CNY	0.0%

Peer EBITDA Comparison of China Pioneer Pharma Holdings Limited

Name	EBITDA	EBITDA Difference
China Healthwise Holdings Limited	-117.45 Million HKD	271.881%
Tycoon Group Holdings Limited	147.38 Million HKD	-36.972%
Beijing Tong Ren Tang Chinese Medicine Company Limited	779.54 Million HKD	74.103%